3. Included studies with data on oestrogen dose.
Study | Design | Outcome |
Non‐use Event (n)/Total (n) |
20 µg E2 Event (n)/Total (n) |
30 to 49 µg E2 Event (n)/Total (n) |
≥ 50 µg E2 Event (n)/Total (n) |
Chang 1999 | Case‐control | Ischemic stroke | 42/188 | — | — | 9/23 |
Heinemann 1998 | Case‐control | Ischemic stroke | 96/353 | — | — | 15/38 |
Lidegaard 2012a | Cohort | Both | * | * | * | * |
Rosenberg 2001 | Case‐control | Myocardial infarction | 591/3301 | — | — | 4/7 |
Shapiro 1979 | Case‐control | Myocardial infarction | 205/1812 | — | — | 18/107 |
Sidney 1998 | Case‐control | Myocardial infarction | 255/1159 | — | — | 2/7 |
Tzourio 1995 | Case‐control | Ischemic stroke | 25/135 | 2/7 | 30/76 | 8/15 |
Abbreviations: µg: micrograms; E2: ethinylestradiol; n: number.
* Adjusted effect estimates extracted